生物素导向组装靶向模块化脂质体及其在体外转染人肝癌细胞的研究。

Biotin-directed assembly of targeted modular lipoplexes and their transfection of human hepatoma cells in vitro.

机构信息

Pfizer Molecular Biology Research Facility, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.

出版信息

Drug Deliv. 2010 Aug;17(6):426-33. doi: 10.3109/10717541003777530.

Abstract

The asialoglycoprotein receptor, which is abundantly and near exclusively expressed on hepatocytes, has received much attention in the design of non-viral hepatotropic DNA delivery systems. Thus, asialoglycoproteins and hexopyranosyl ligands have been coupled to DNA-binding cationic polymers and liposomes in the assembly of complexes intended for uptake by liver parenchymal cells. The aim of the study was to construct a hepatocyte-targeted multimodular liposome-based transfecting complex, in which the biotin-streptavidin interaction provides the cohesive force between the ligand asialorosomucoid and the liposome bilayer, and to evaluate its transfection capabilities in the hepatocyte-derived human transformed cell line HepG2. Dibiotinylated asialoorosomucoid was attached to cationic liposomes constructed from 3beta[N-(N',N'-dimethylaminopropane)-carbamoyl] cholesterol (Chol-T):dioleoylphosphatidylethanolamine:biotinylcholesterylformylhydrazide (MSB1) (48:50:2 mole ratio) through streptavidin interposition. Liposome-pGL3 DNA interactions were studied by gel band shift and ethidium displacement assays. The cytotoxicity of assemblies was evaluated in the HepG2 cell line and transfection capabilities determined by measuring the activity of the transgene luciferase. Binding assays showed that all DNA was liposome associated at a DNA (negative):liposome (positive) charge ratio of 1:1. Accommodation of a streptavidin dibiotinylated asialoorosomucoid assembly was achieved at a DNA:liposome:streptavidin dibiotinylated asialoorosomucoid ratio of 1:4:9 (weight basis). Complexes showed optimal transfection activity at this ratio, which was reduced 10-fold by the presence of the competing ligand asialofetuin. The streptavidin-biotin interaction has been applied for the first time to the assembly of hepatocyte-targeted lipoplexes that display asialoorosomucoid and that are well tolerated by a human hepatoma cell line in which transfection is demonstrably achieved by receptor mediation. Favorable size and charge ratio characteristics suggest that this system may be suitable for in vivo application.

摘要

去唾液酸糖蛋白受体在肝实质细胞上丰富且近独占地表达,因此在设计非病毒嗜肝性 DNA 传递系统方面受到了广泛关注。因此,去唾液酸糖蛋白和己糖基配体已被偶联到 DNA 结合阳离子聚合物和脂质体上,以组装用于被肝实质细胞摄取的复合物。本研究的目的是构建一种肝靶向的多模块脂质体转染复合物,其中生物素-链霉亲和素相互作用提供了配体去唾液酸糖蛋白和脂质体双层之间的内聚力,并评估其在肝源性人转化细胞系 HepG2 中的转染能力。双生物素化去唾液酸糖蛋白通过链霉亲和素介入被连接到由 3β[N-(N',N'-二甲氨基丙基)-碳酰胺]胆固醇(Chol-T):二油酰基磷脂酰乙醇胺:生物素化胆固醇甲酰肼(MSB1)(48:50:2 摩尔比)组成的阳离子脂质体上。通过凝胶带移位和溴化乙锭置换测定研究了脂质体-pGL3 DNA 相互作用。在 HepG2 细胞系中评估了组装物的细胞毒性,并通过测量转基因荧光素酶的活性确定了转染能力。结合测定表明,在 DNA(负):脂质体(正)电荷比为 1:1 时,所有 DNA 都与脂质体结合。在 DNA:脂质体:链霉亲和素双生物素化去唾液酸糖蛋白比为 1:4:9(重量基础)时,可以容纳一个链霉亲和素双生物素化去唾液酸糖蛋白组装体。在该比例下,复合物显示出最佳的转染活性,当存在竞争配体去唾液酸胎球蛋白时,该活性降低 10 倍。生物素-链霉亲和素相互作用首次应用于组装肝靶向脂质体,该脂质体显示去唾液酸糖蛋白,并被人肝癌细胞系耐受良好,其中转染通过受体介导得到证实。有利的大小和电荷比特征表明,该系统可能适用于体内应用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索